Sjögren Clinical Trials in Brest
5 recruitingBrest, France
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Amgen844 enrolled174 locationsNCT06747949
Recruiting
Phase 1Phase 2
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
Novartis Pharmaceuticals27 enrolled11 locationsNCT07048197
Recruiting
Phase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099
Recruiting
Phase 2
New Clinical End-points in Patients With Primary Sjögren's Syndrome
Primary Sjögren's Syndrome (pSS)
Assistance Publique - Hôpitaux de Paris300 enrolled7 locationsNCT05113004
Recruiting
Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort
Primary Sjögren's Syndrome (pSS)
University Hospital, Brest100 enrolled1 locationNCT03681964